PRODUCT DESCRIPTION:

Cefpodoxime is an advanced third-generation cephalosporin antibiotic designed for oral administration.

It exhibits broad-spectrum bactericidal activity by inhibiting bacterial cell wall synthesis and is stable against many β-lactamase–producing strains, making it a potent agent against both Gram-positive and Gram-negative bacteria.

It is well-absorbed from the GI tract and demonstrates excellent clinical efficacy in the treatment of respiratory, skin, urinary, and ENT infections.

Cefpodoxime Tablets & Dry Syrup are preferred for their safety profile, rapid onset, and convenient oral dosing, especially in outpatient and step-down therapy settings.

Formulation & Presentation:

• Dosage Form: Dry Syrup
• Presentation: Available in HDPE Bottle with measuring Cap (As per market requirement)
• Available Strengths:
  • Cefpodoxime Dry Syrup 30 ML
  • Cefpodoxime Dry Syrup 30 ML
• Route of Administration: Oral (As per physician’s discretion or therapeutic indication)

Therapeutic Indications:

• Community-acquired Pneumonia
• Acute Tonsillitis & Pharyngitis
• Sinusitis
• Otitis Media
• Urinary Tract Infections
• Skin & Soft Tissue Infections
• Gonorrhea (uncomplicated)
• Typhoid Fever
• Lower Respiratory Tract Infections (including bronchitis)

Side Effects:

• COMMON:
  • Nausea
  • Diarrhea
  • Abdominal discomfort
  • Headache
  • Mild rash or pruritus
• SERIOUS (RARE):
  • Hypersensitivity reactions including anaphylaxis
  • Clostridioides difficile–associated diarrhea
  • Hepatotoxicity
  • Stevens-Johnson Syndrome
  • Blood dyscrasias (e.g., neutropenia, eosinophilia)
• PRECAUTIONS:
  • Caution in patients allergic to cephalosporins or penicillins
  • Dose adjustment may be required in renal impairment
  • Not recommended for infants under 2 months of age
  • Use during pregnancy only if clearly needed

Monitor liver enzymes during long-term therapy